Skip to content

Medical emergency? What to do

Sales of biogenerics in US, Europe to soar

3-RXPublished September 6, 20051 min read

Key points

  • Copycat versions of expensive biotech drugs could see $16.4 billion in sales in the United States and Europe by 2011 once regulatory curbs on so-called biogenerics use are gone, a study showed on Monday.
  • But global consulting group Frost & Sullivan said in an analysis of the sector on Monday that the outlook for biogenerics was fast improving.
  • Generic drugmakers are keen to tap into the market by producing cheaper versions of products such as human growth hormone, transgenic insulin and erythropoietin (EPO), the "blood boosting" medicine.
  • Although no generic version of a biotech medicine has yet been approved, Europe is further ahead than the United States in the matter, having already established a legal framework, or "biosimilar", drug applications.

Copycat versions of expensive biotech drugs could see $16.4 billion in sales in the United States and Europe by 2011 once regulatory curbs on so-called biogenerics use are gone, a study showed on Monday.

To date, biotech drugs made using genetic engineering have been immune from generic competition, since regulators in these major markets have been slow to set clear approval rules and many are still patent-protected.

But global consulting group Frost & Sullivan said in an analysis of the sector on Monday that the outlook for biogenerics was fast improving.

"As regulatory guidelines are introduced over the next two to three years and some of the biggest biopharmaceutical blockbusters lose patent protection, the biogenerics market is expected to see exceptional growth and rapidly reach billion-dollar levels," said Frost & Sullivan analyst Himanshu Parmar.

Generic drugmakers are keen to tap into the market by producing cheaper versions of products such as human growth hormone, transgenic insulin and erythropoietin (EPO), the "blood boosting" medicine.

Frost & Sullivan said products like these could reach markets in North America and Europe by 2006-07 and potentially generate sales of $16.39 billion by 2011.

Although no generic version of a biotech medicine has yet been approved, Europe is further ahead than the United States in the matter, having already established a legal framework, or "biosimilar", drug applications.

Europe also has written guidelines detailing how the new rules will apply.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.